Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $18.6900 (-5.8%) ($18.6600 - $18.6900) on Thu. Jan. 20, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.06% (three month average) | RSI | 19 | Latest Price | $18.6900(-5.8%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -4.6% a day on average for past five trading days. | Weekly Trend | EDIT declines -12.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(70%) IWO(64%) IBUY(62%) IWC(62%) IWM(61%) | Factors Impacting EDIT price | EDIT will decline at least -2.03% in a week (0% probabilities). VIXM(-33%) UUP(-16%) VXX(-12%) TBT(-10%) UNG(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.03% (StdDev 4.06%) | Hourly BBV | -2.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $0.28(-98.5%) | Resistance Level | $24.94 | 5 Day Moving Average | $20.5(-8.83%) | 10 Day Moving Average | $22.56(-17.15%) | 20 Day Moving Average | $24.94(-25.06%) | To recent high | -54.1% | To recent low | 0% | Market Cap | $1.161b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |